Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23082-3

Guardado en:

Detalles Bibliográficos
Autores principales:	Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/82ec3060aff24d5ab09af11137ccc875
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:82ec3060aff24d5ab09af11137ccc875
record_format	dspace
spelling	oai:doaj.org-article:82ec3060aff24d5ab09af11137ccc8752021-12-02T14:49:31ZAuthor Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors10.1038/s41467-021-23082-32041-1723https://doaj.org/article/82ec3060aff24d5ab09af11137ccc8752021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23082-3https://doaj.org/toc/2041-1723A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23082-3Sho IketaniFarhad ForouharHengrui LiuSeo Jung HongFang-Yu LinManoj S. NairArie ZaskYaoxing HuangLi XingBrent R. StockwellAlejandro ChavezDavid D. HoNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Sho Iketani Farhad Forouhar Hengrui Liu Seo Jung Hong Fang-Yu Lin Manoj S. Nair Arie Zask Yaoxing Huang Li Xing Brent R. Stockwell Alejandro Chavez David D. Ho Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
description	A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23082-3
format	article
author	Sho Iketani Farhad Forouhar Hengrui Liu Seo Jung Hong Fang-Yu Lin Manoj S. Nair Arie Zask Yaoxing Huang Li Xing Brent R. Stockwell Alejandro Chavez David D. Ho
author_facet	Sho Iketani Farhad Forouhar Hengrui Liu Seo Jung Hong Fang-Yu Lin Manoj S. Nair Arie Zask Yaoxing Huang Li Xing Brent R. Stockwell Alejandro Chavez David D. Ho
author_sort	Sho Iketani
title	Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
title_short	Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
title_full	Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
title_fullStr	Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
title_full_unstemmed	Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
title_sort	author correction: lead compounds for the development of sars-cov-2 3cl protease inhibitors
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/82ec3060aff24d5ab09af11137ccc875
work_keys_str_mv	AT shoiketani authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT farhadforouhar authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT hengruiliu authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT seojunghong authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT fangyulin authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT manojsnair authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT ariezask authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT yaoxinghuang authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT lixing authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT brentrstockwell authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT alejandrochavez authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors AT daviddho authorcorrectionleadcompoundsforthedevelopmentofsarscov23clproteaseinhibitors
_version_	1718389457029169152

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Ejemplares similares